NCT06090214View on ClinicalTrials.gov

Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE)

NANot yet recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

September 1, 2025

Study Completion Date

December 1, 2025

Conditions
Ethmoid Sinus TumorAdenocarcinomaCirculating Tumor Cell
Interventions
DIAGNOSTIC_TEST

Liquid biopsy

For cases: 60 mL blood sample (40 ml for CellSave analysis and 20ml for collection) at visit1 then 20 ml for CellSave analysis at visit2 and visit3 For controls: 40 ml (20ml for CellSave analysis and 20ml for collection) at visit1

All Listed Sponsors
collaborator

GEFLUC Occitanie

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT06090214 - Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE) | Biotech Hunter | Biotech Hunter